Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative dexmedetomidine for prevention of postoperative catheter-related bladder discomfort after TURBT
ChiCTR2000034657Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in cystitis (4 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Incidence of moderate or severe catheter-related bladder discomfort at 0 hours postoperatively. Started Jul 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cystitis
Beyond the preview
Go deeper on ChiCTR2000034657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034657.